BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260610
DTSTAMP:20260514T232715
CREATED:20260211T102827Z
LAST-MODIFIED:20260211T102827Z
UID:42871-1780358400-1781049599@www.pharmajournalist.com
SUMMARY:5th ALS Drug Development Summit
DESCRIPTION:The 5th ALS Drug Development Summit returns to Boston as the ultimate platform honing industry R&D for safer\, more effect and patient-relevant drugs that serve the community\, driving a cure for sporadic and familial ALS. \nWith a brand-new agenda spanning early target exploration through to clinical design\, biomarker strategy\, and regulatory engagement\, attendees will gain comprehensive insights into genetically validated targets\, the evolving biology of TDP 43\, adaptive trial design\, and embedding the patient voice throughout development. \nJoin us for 3 days of unmissable data-driven content\, with 2 tracks spanning discovery to access for the whole team: \nTrack A: Discovery\, Preclinical & Translational – designed for CSOs\, pre-clinical researchers\, discovery scientists\, directors of biology and research\, novel modality scientists\, in viva/in vitro modelling experts and many more\, connect with an intimate group of discovery and preclinical experts for a more discursive session. \nTrack B: Clinical & Regulatory – tailor-made for medical directors\, CMOs\, clinical program leaders\, translational and clinical development heads and clinicians and more; share expertise from diverse clinical challenges and innovation in ALS. \nDesigned for biotech\, pharma\, academia\, and patient advocacy stakeholders\, this unique forum will unite 100+ senior experts and 30+ speakers from companies including AbbVie\, Biogen\, Novartis\, Eli Lilly\, QurAlis\, Prilenia\, Sanofi\, and many more. \nDiscover the full 2026 event guide now to explore all speakers and sessions – https://ter.li/28a6lw
URL:https://www.pharmajournalist.com/event/5th-als-drug-development-summit/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR